MUMBAI, India, June 27 -- Intellectual Property India has published a patent application (202527053047 A) filed by Tuojie Biotech (SHANGHAI) Co. Ltd., Shanghai, on May 31, for 'oligonucleotide comprising lipophilic monomer and use thereof in non-liver delivery.'
Inventor(s) include Hou, Zhe; Ma, Ningning; Huang, Xiaoling; Li, Yuqi; and Li, Yunfei.
The application for the patent was published on June 27, under issue no. 26/2025.
According to the abstract released by the Intellectual Property India: "An oligonucleotide comprising a lipophilic monomer and a use thereof in non-liver delivery. Specifically, the present disclosure relates to an oligonucleotide, comprising an antisense strand complementary to a target gene, a sense strand complementary to the antisense strand, and one or more compounds represented by formula (I). The present disclosure further relates to a pharmaceutical composition comprising the oligonucleotide, and a medicinal use of the oligonucleotide and/or the pharmaceutical composition."
The patent application was internationally filed on Dec. 13, 2023, under International application No.PCT/CN2023/138483.
Disclaimer: Curated by HT Syndication.
